FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:1855-1857 November 6, 2003 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Goss, P. E. PubMed Citation

In this issue of the Journal, Goss et al.¹ report results from a trial that will have a considerable effect on the treatment of early-stage breast cancer. The study was led by the National Cancer Institute of Canada Clinical Trials Group and was a joint effort of the North American Intergroup and the Breast International Group. These organizations are to be commended for a well-conceived and well-conducted clinical trial. Their work is an excellent example of the way in which clinical-trial organizations can work together efficiently and expeditiously to investigate clinical questions of common interest.

Previous trials have shown that . . . [Full Text of this Article]

Source Information

From the National Surgical Adjuvant Breast and Bowel Project (J.B., N.W.); the Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh (J.B.); and the Department of Human Oncology, Allegheny General Hospital (N.W.) — all in Pittsburgh.

This editorial was published at www.nejm.org on October 9, 2003.

Related Letters:

Letrozole in Breast Cancer
Buzdar A. U., Hietanen P., Mäkelä M., Shahab N., Harris S. R., Hellman S., Hellman D., Goss P. E., Ingle J. N., Pater J. L., Bryant J., Wolmark N., Burstein H. J.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:727-730, Feb 12, 2004. Correspondence

This article has been cited by other articles:

• Ng, R., Pond, G. R., Tang, P. A., MacIntosh, P. W., Siu, L. L., Chen, E. X. (2008). Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006. Ann Oncol 19: 481-486 [Abstract] [Full Text]  
• Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., Livingston, R. B., Davidson, N. E., Norton, L., Perez, E. A., Abrams, J. S., Cameron, D. A., Palmer, M. J., Pater, J. L. (2005). Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17. JNCI J Natl Cancer Inst 97: 1262-1271 [Abstract] [Full Text]  
• Dignam, J. J. (2005). Early Viewing of Noninferiority Trials in Progress. JCO 23: 5461-5463 [Full Text]  
• Mann, B. S., Johnson, J. R., Kelly, R., Sridhara, R., Williams, G., Pazdur, R. (2005). Letrozole in the Extended Adjuvant Treatment of Postmenopausal Women with History of Early-Stage Breast Cancer Who Have Completed 5 Years of Adjuvant Tamoxifen. Clin. Cancer Res. 11: 5671-5677 [Abstract] [Full Text]  
• Jones, K. L, Buzdar, A. U (2004). A review of adjuvant hormonal therapy in breast cancer. Endocr Relat Cancer 11: 391-406 [Abstract] [Full Text]  
• Piccart-Gebhart, M. J. (2004). New Stars in the Sky of Treatment for Early Breast Cancer. NEJM 350: 1140-1142 [Full Text]  
• Buzdar, A. U., Hietanen, P., Makela, M., Shahab, N., Harris, S. R., Hellman, S., Hellman, D., Goss, P. E., Ingle, J. N., Pater, J. L., Bryant, J., Wolmark, N., Burstein, H. J. (2004). Letrozole in Breast Cancer. NEJM 350: 727-730 [Full Text]  
• (2003). Letrozole, After Tamoxifen, Reduces Risk for Breast Cancer Recurrence. JWatch General 2003: 1-1 [Full Text]